The Life Sciences BPO Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Life Sciences BPO Market:
https://www.thebusinessresearchcompany.com/report/life-sciences-bpo-global-market-report
According to The Business Research Company’s Life Sciences BPO Global Market Report 2024, The life sciences bpo market size has grown rapidly in recent years. It will grow from $239.74 billion in 2023 to $266.44 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to focus on patient-centric healthcare solutions, increasing data management challenges, market competition and time-to-market pressure, globalization and expansion, complexity in clinical trials..
The life sciences bpo market size is expected to see rapid growth in the next few years. It will grow to $390.42 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for drug development support, focus on real-world evidence and data analytics, globalization and expansion strategies, increased emphasis on precision medicine, rise in outsourcing clinical trial management.. Major trends in the forecast period include ai and advanced analytics integration, virtual trials and remote monitoring, focus on regulatory compliance solutions, precision medicine and personalized healthcare, blockchain and data security solutions..
The increasing healthcare expenditure is expected to propel the growth of the life sciences BPO market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare-related goods and services, encompassing various categories such as medical treatments, medications, hospital stays, doctor visits, medical devices, health insurance, and related healthcare expenses. Life sciences BPO solutions aid healthcare companies in delivering crucial drugs, devices, and services to patients, with the growing healthcare investments further enhancing their ability to optimize costs, expedite development, hasten new treatment market entry, and reduce research and development expenses. For instance, in November 2022, according to the Canadian Institute for Health Information (CIHI), a Canada-based government organization that is dedicated to providing essential information on Canada's health systems, the total healthcare expenditure in Canada was $305 billion in 2020, which was estimated to increase to $328 billion in 2021 and $331 billion, or $8,563 per Canadian, in 2022. Therefore, increasing healthcare expenditure is driving the growth of the life sciences BPO market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13293&type=smp
The life sciences bpo market covered in this report is segmented –
1) By Services: Pharmaceutical Outsourcing, Medical devices outsourcing, Contract sales and marketing outsourcing, Other Services
2) By Application: Clinical Testing Methods, Environmental Testing Methods, Other Applications
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
Major companies operating in the life sciences BPO market are increasing their focus on introducing SaaS-based life sciences solutions such as PRECIZON to maximize their profits in the market. PRECIZON is a SaaS-based life sciences analytics solution that enables companies to reliably run analytics in the cloud and centrally manage analytics. For instance, in August 2021, WNS Limited, an India-based business process management company, launched PRECIZON, a sophisticated SaaS-based Pharma Competitive Intelligence (CI) solution to deliver cloud-based competitive intelligence for the life sciences industry. PRECIZON streamlines information collection from public and commercial data sources, curation inside the platform, and dissemination to end users through preferred channels to offer a 360° solution for CI needs. This tool is committed to providing insightful information that may be used to make more informed decisions and, over time, speed up the go-to-market process.
The life sciences bpo market report table of contents includes:
1. Executive Summary
2.Life Sciences BPO Market Characteristics
3.Life Sciences BPO Market Trends And Strategies
4.Life Sciences BPO Market analysis
5.Life Sciences BPO Market Size And Growth
6.Life Sciences BPO Segmentation
7.Life Sciences BPO Regional And Country Analysis
.
.
.
27.Life Sciences BPO Competitive Landscape And Company Profiles
28.Life Sciences BPO Key Mergers And Acquisitions
29.Life Sciences BPO Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Accenture PLC
- Atos SE
- Catalent Inc.
- Covance Inc.
- Genpact Ltd.
- ICON PLC
- Infosys Ltd.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Life Sciences BPO Market: IntroductionTransparency Market Research has published a new report titled, ‘Global Life Sciences BPO Market’.
According to the report, the global life sciences BPO market was valued at ~US$ 214 Bn in 2018 and is projected to expand at a CAGR of ~8% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1782Broad and Growing Product Pipeline to Drive Adoption of Advanced Life Sciences BPORise in demand for new drugs and novel therapies for treatment of diseases such as cancer and immunological disorders coupled with the evolving research & development process has increased the number of compounds in pipeline in the last decade.
This in turn drives the global life sciences BPO market.Efforts to Optimize Costs and Development TimeEscalating costs of conducting clinical trials, requirement of data quality, enrollment targets, financial demands regarding setting up of a clinical research practice, and other management related activities drive the outsourcing services.
According to the Tufts Center for the Study of Drug Development, outsourcing to CROs has supported companies in keeping R head counts stable, even though the number of active clinical trials across the world has increased by 80%.
Moreover, trials outsourced to CROs are, on average, completed 30% sooner than in-house clinical trials, providing an average timesaving of four to five months.Request COVID Analysis on Life Sciences BPO Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=1782Contract Manufacturing Organizations to Lead Global MarketBased on service type, the contract manufacturing organizations segment dominated the global market in 2018.
Significant increase in research and development costs, technological developments, and product innovation, which accounts for high R costs prompt several pharmaceutical and medical device companies to outsource preclinical services to CROs.
